Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis

By M. Doenhoff, D. Cioli, J. Utzinger. Current Opinion in Infectious Diseases, 2008

752 citations recorded by the source corpus.

Subfields: Ecology, Parasitology, Public Health, Environmental and Occupational Health

View Paper: https://www.semanticscholar.org/paper/f06fca8e31332d86c471332710e9505444f1c02a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Michael Woelfle
2. J. Seerden
3. P. Olliaro
4. Jesse M de Gooijer
5. M. Todd
6. Kees Pouwer
7. Matthew A. Kayala

Citations in the corpus

• Resolution of Praziquantel (2011, background): “Over the past decades several compounds have been used for the treatment of schistosomiasis,[4–6] but today there is only one drug of choice, a highly effective small molecule called praziquantel (PZQ).[7,8] PZQ is produced on a very large scale”